– Se ha administrado la primera dosis a los pacientes en el estudio clínico VIRAGE2 de Fase IIa, que evalúa la administración con mayor frecuencia de VCN-01 (zabilugene almadenorepvec), cuyo objetivo es mejorar los resultados del tratamiento en pacientes con adenocarcinoma ductal pancreático (PDAC) metastásico –
METTAWA, Ill., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Brunswick Corporation (NYSE: BC) will release its 2026 third quarter financial results on Thursday, October 29, 2026, before the market opens by way of an advisory release, notifying the public that the complete and full-text results will be available on the Company’s website. The results will also…
VANCOUVER, BRITISH COLUMBIA, Oct. 08, 2026 (GLOBE NEWSWIRE) -- HI-VIEW RESOURCES INC. (“Hi-View” or the “Company”) (CSE: GXLD; OTCQB: GXLDF; FSE: B630) announces that it has acquired additional contiguous claims to its Junker Property in the Toodoggone Gold & Copper District of northern British Columbia.
Related Bing News Results Globe Newswire, World News and Updates | Calgary Sun Tue, 29 Sep 2026 16:13:00 GMT MONTRÉAL, Sept. 29, 2026 (GLOBE NEWSWIRE) — Top Aces Inc. (“Top Aces”) today announced that it has qualified as a supplier under three streams of the Government of Canada’s Defence Drone Initiative ...
